skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

COVID-19 and the impact on the clinical trial space

Clinical trials for therapeutic areas outside of COVID-19 are experiencing disruptions and delays as social distancing measures and travel  restrictions are implemented across the world. Many sectors of the industry are also shifting R&D priorities towards finding new vaccines and treatments for COVID-19 at the expense of other indications. However, the biopharmaceutical industry is compelled to maintain its momentum in R&D in order to bring safe and effective therapies to market while protecting investments already made by companies.

COVID19 Whitepaper





電話:+81 (0)3 6273 4260